Prescription Patterns of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Chronic Kidney Disease
碩士 === 高雄醫學大學 === 臨床藥學研究所 === 96 === Background and objectives: Chronic kidney disease (CKD) affected more than 50 million people, and more than 1 million of them received kidney replacement therapy. Based on data from the US Renal Data System, the highest rates of incident and prevalent end stage r...
Main Authors: | Pei-Tzu Wang, 王珮慈 |
---|---|
Other Authors: | Yaw-Bin Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/90978229665587813123 |
Similar Items
-
Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease
by: Pei-Tzu Wang, et al.
Published: (2012-09-01) -
Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01) -
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01) -
The Renoprotective Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Chronic Kidney Disease
by: Wen-Chuan Lin, et al.
Published: (2002) -
Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury
by: P R Shah, et al.
Published: (2011-01-01)